Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Dipharma
Dipharma
Activities:
Ingredients
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Manufacturing
Dipharma expands CDMO offering with new QC lab in the US
New lab has enabled Italy-based Dipharma to now offer full services from discovery to marketed drugs
Manufacturing
Dipharma Francis Srl sell Amino Chemicals to ABA Chemicals
Dipharma Francis Srl, a European manufacturer of Active Pharmaceutical Ingredients, completed the sale of its subsidiary Amino Chemicals, based in Malta, to ABA Chemicals Corporation, China
Research & Development
New room-temperature stable Carglunic acid tablets
Carglumic acid is a therapeutic tool in the management of inborn metabolic disorders affecting the urea cycle
Pharmaceutical
Disanit authorised for marketing in Europe
Dipharma's Disanit (Nitisinone capsules 2, 5 and 10mg) is now under marketing authorisation (MA) evaluation in the EU.
Distribution
Dipharma and Alvogen launch Diterin in South Korea
First drug commercially available for the treatment of hyperphenylalaninemia due to phenylketonuria
Subscribe now